To see the other types of publications on this topic, follow the link: Gene-targeted therapy.

Books on the topic 'Gene-targeted therapy'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 42 books for your research on the topic 'Gene-targeted therapy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Lao, Yeh-Hsing. Nanosystems for Gene Editing and Targeted Therapy. [publisher not identified], 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ward, Christopher Michael. Development of folate-targeted non-viral vectors for systemic cancer gene therapy. University of Birmingham, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bo, Xuenong, and Joost Verhaagen. Gene delivery and therapy for neurological disorders. Humana Press, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Houghton, Peter J., and Robert Arceci. Molecularly targeted therapy for childhood cancer. Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Slabý, Ondřej. MicroRNAs in solid cancer: From biomarkers to therapeutic targets. Nova Science, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kahn, Michael. Targeting the Wnt pathway in cancer. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

N, Syrigos Konstantinos, and Harrington Kevin J. 1958-, eds. Targeted therapy for cancer. Oxford University Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Williams, Sophie I., and Christopher E. Rogers. HER2 and cancer: Mechanism, testing, and targeted therapy. Nova Biomedical Books, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

W, Siemann Dietmar, ed. Vascular-targeted therapies in oncology. J. Wiley, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Biotargets Of Cancer In Current Clinical Practice. Humana Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Bologna, Mauro. Biotargets of Cancer in Current Clinical Practice. Humana Press, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Bologna, Mauro. Biotargets of Cancer in Current Clinical Practice. Humana, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Smalley, Keiran. Current Challenges in Personalized Cancer Medicine. Elsevier Science & Technology Books, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Smalley, Keiran. Current Challenges in Personalized Cancer Medicine. Elsevier Science & Technology Books, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Bo, Xuenong, and Joost Verhaagen. Gene Delivery and Therapy for Neurological Disorders. Humana Press, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Board on Health Sciences Policy, Clare Stroud, National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, and Forum on Neuroscience and Nervous System Disorders. Advancing Gene-Targeted Therapies for Central Nervous System Disorders: Proceedings of a Workshop. National Academies Press, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

National Academies of Sciences, Engineering, and Medicine. Advancing Gene-Targeted Therapies for Central Nervous System Disorders: Proceedings of a Workshop. National Academies Press, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Kesharwani, Rajesh K., and Krishna Misra. Biotechnology in the Modern Medicinal System: Advances in Gene Therapy, Immunotherapy, and Targeted Drug Delivery. Apple Academic Press, Incorporated, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Kesharwani, Rajesh K., and Krishna Misra. Biotechnology in the Modern Medicinal System: Advances in Gene Therapy, Immunotherapy, and Targeted Drug Delivery. Apple Academic Press, Incorporated, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Kesharwani, Rajesh K., and Krishna Misra. Biotechnology in the Modern Medicinal System: Advances in Gene Therapy, Immunotherapy, and Targeted Drug Delivery. Apple Academic Press, Incorporated, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Kesharwani, Rajesh K., and Krishna Misra. Biotechnology in the Modern Medicinal System: Advances in Gene Therapy, Immunotherapy, and Targeted Drug Delivery. Apple Academic Press, Incorporated, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Kesharwani, Rajesh K., and Krishna Misra. Biotechnology in the Modern Medicinal System: Advances in Gene Therapy, Immunotherapy, and Targeted Drug Delivery. Apple Academic Press, Incorporated, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Houghton, Peter J., and Robert J. Arceci. Molecularly Targeted Therapy for Childhood Cancer. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Sarkar, Fazlul H. MicroRNA Targeted Cancer Therapy. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Sarkar, Fazlul H. MicroRNA Targeted Cancer Therapy. Springer, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Sarkar, Fazlul H. MicroRNA Targeted Cancer Therapy. Springer London, Limited, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Targeted therapies in oncology. Informa Healthcare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

(Editor), Giuseppe Giaccone, and Jean-Charles Soria (Editor), eds. Targeted Therapies in Oncology. Informa Healthcare, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Borden, Ernest C. Melanoma: Biologically Targeted Therapeutics. Humana Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Borden, Ernest C. Melanoma: Biologically Targeted Therapeutics. Humana, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Sibilia, Maria, Christoph C. Zielinski, Rupert Bartsch, and Thomas W. Grunt. Drugs for HER-2-Positive Breast Cancer. Springer Basel AG, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

Medicine, Institute of, Board on Health Care Services, Harold L. Moses, National Academies of Sciences, Engineering, and Medicine, and Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies. Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine. National Academies Press, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Medicine, Institute of, Board on Health Care Services, Harold L. Moses, National Academies of Sciences, Engineering, and Medicine, and Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies. Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine. National Academies Press, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Medicine, Institute of, Board on Health Care Services, Harold L. Moses, National Academies of Sciences, Engineering, and Medicine, and Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies. Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine. National Academies Press, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine. National Academies Press, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Targeted Interference with Signal Transduction Events (Recent Results in Cancer Research). Springer, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Siemann, Dietmar W. Vascular-Targeted Therapies in Oncology. Wiley & Sons, Limited, John, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Cortés, Javier, Leticia Mattos-Arruda, Mary Falzon, Angelica Fasolo, and Ricardo H. Alvarez. Handbook of HER2-Targeted Agents in Breast Cancer. Springer Healthcare, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Mattos-Arruda, Leticia, Ricardo H. Alvarez, and Javier Cortes. Handbook of Her2-Targeted Agents in Breast Cancer. Springer Healthcare, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Gandy, Michael, Luca Gianni, Ricardo H. H. Alvarez, et al. Handbook of HER2-targeted agents in breast cancer. Springer Healthcare, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Roddy, Edward, and Michael Doherty. Calcium pyrophosphate crystal deposition (CPPD). Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0142.

Full text
Abstract:
Calcium pyrophosphate crystal deposition (CPPD) in articular cartilage is a common age-related phenomenon. Recent important advances in our understanding of the pathophysiology of pyrophosphate metabolism include the identification of a mutation within the ANK gene which associates with familial CPPD, and elucidation of the interleukin-1β‎ (IL-1β‎)-dependent mechanisms by which crystals invoke an inflammatory response. Risk factors for CPPD include age, prior joint damage and osteoarthritis, genetic factors, and occasionally metabolic diseases (hyperparathyroidism, haemochromatosis, hypomagnes
APA, Harvard, Vancouver, ISO, and other styles
42

Kühn, Wolfgang, and Gerd Walz. The molecular basis of ciliopathies and cyst formation. Edited by Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0303.

Full text
Abstract:
Abnormalities of the cilium, termed ‘ciliopathies’, are the prime suspect in the pathogenesis of renal cyst formation because the gene products of cystic disease-causing genes localize to them, or near them. However, we only partially understand how cilia maintain the geometry of kidney tubules, and how abnormal cilia lead to renal cysts, and the diverse range of diseases attributed to them. Some non-cystic diseases share pathology of the same structures. Although still incompletely understood, cilia appear to orient cells in response to extracellular cues to maintain the overall geometry of a
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!